Stemedica and Scripps to Jointly Investigate Therapeutic Effect of...

Stemedica and Scripps to Jointly Investigate Therapeutic Effect of Ischemia Tolerant Mesenchymal Stem Cells and Stem Cell Factors in Lung Injury and Sepsis Stemedica Cell Technologies, Inc., a leading manufacturer of adult ischemia tolerant allogeneic stem cells and stem cell factors announced that the Company has signed an agreement with The ... (more)

http://www.prweb.com/releases/stemedica-scripps-ards/stem-cell-factors-sepsis/prweb10263983.htm